Generic drugmaker Mylan on Tuesday reported lower-than-expected fourth-quarter profit and forecast 2019 earnings well below Wall Street estimates, as it grapples with significant problems at its Morgantown, West Virginia, plant. Mylan said the lower forecast was due to higher projected sales, marketing and research and development costs, and its shares fell about 10 percent. Mylan… Read More »
Brenden was the first patient enrolled in what became a nine-patient, four-center trial that also involved patients at the National Institutes of Health (NIH) in Maryland, the University of California at Los Angeles, and Great Ormond Street Hospital for Children in London. The trial, funded by the NIH and the California Institute for Regenerative Medicine,… Read More »
A whole constellation of things factor into a solid night’s sleep: what you did at the gym that day, how long ago you finished up an emergency latte, how late you stayed up watching Chuck pre-zzzs, and, of course, your mattress. In fact, more than 75 percent of those surveyed by the National Sleep Foundation… Read More »
Superbug is a nickname for an antibiotic resistant bacterium. They are a major health concern. It is estimated that at least 70,000 people die each year from superbug infections. The really bad news is that as more bacteria evolve to become resistant to our antibiotics it is projected that the annual death toll from superbug… Read More »